We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORTX
6276
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$57K ﹤0.01%
418
-4
-0.9% -$486
HOLD
6277
DELISTED
AdvisorShares North Square McKee Core Reserves ETF
HOLD
$57K ﹤0.01%
569
-276
-33% -$27.6K
SWIR
6278
DELISTED
Sierra Wireless
SWIR
$57K ﹤0.01%
5,989
-335
-5% -$3.26K
ECC
6279
Eagle Point Credit Company
ECC
$513M
$56K ﹤0.01%
3,865
+3,200
+481% +$48.7K
EVG
6280
Eaton Vance Short Duration Diversified Income Fund
EVG
$143M
$56K ﹤0.01%
4,162
+1,136
+38% +$15.1K
MRAM icon
6281
Everspin Technologies
MRAM
$405M
$56K ﹤0.01%
10,646
+10,246
+2,562% +$56K
SYBX
6282
DELISTED
Synlogic
SYBX
$56K ﹤0.01%
1,455
+584
+67% +$19.7K
BLCM
6283
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$56K ﹤0.01%
4,342
+690
+19% +$6.37K
CCI.PRA
6284
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
$56K ﹤0.01%
44
-39
-47% -$47.9K
FLAG
6285
DELISTED
FLAG-Forensic Accounting Long-Short ETF
FLAG
$56K ﹤0.01%
1,390
-754
-35% -$29.2K
DDG
6286
DELISTED
Proshares Short Oil & Gas
DDG
$56K ﹤0.01%
2,300
-199
-8% -$5.15K
GSH
6287
DELISTED
Guangshen Railway Co. Ltd
GSH
$56K ﹤0.01%
3,394
-941
-22% -$15.2K
BANC icon
6288
Banc of California
BANC
$2.97B
$55K ﹤0.01%
3,203
-3,004
-48% -$45.4K
CIK
6289
Credit Suisse Asset Management Income Fund
CIK
$134M
$55K ﹤0.01%
16,993
+1,113
+7% +$3.54K
EEA
6290
European Equity Fund
EEA
$76.6M
$55K ﹤0.01%
5,895
-4,105
-41% -$37.8K
HDSN
6291
Hudson Technologies
HDSN
$235M
$55K ﹤0.01%
56,232
+37,571
+201% +$25.2K
LIQT icon
6292
LiqTech
LIQT
$21M
$55K ﹤0.01%
1,179
+30
+3% +$1.54K
PRAA icon
6293
PRA Group
PRAA
$755M
$55K ﹤0.01%
1,515
-9,957
-87% -$353K
SRV
6294
NXG Cushing Midstream Energy Fund
SRV
$216M
$55K ﹤0.01%
1,347
+212
+19% +$8.19K
OBSV
6295
DELISTED
ObsEva SA Ordinary Shares
OBSV
$55K ﹤0.01%
14,497
+3,606
+33% +$18.7K
TERM
6296
DELISTED
EquityCompass Tactical Risk Manager ETF
TERM
$55K ﹤0.01%
2,870
+752
+36% +$13.8K
LVGO
6297
DELISTED
Livongo Health, Inc. Common Stock
LVGO
$55K ﹤0.01%
2,180
-500
-19% -$12K
KOL
6298
DELISTED
VanEck Vectors Coal ETF
KOL
$55K ﹤0.01%
554
-127
-19% -$13.7K
SVA
6299
DELISTED
Sinovac Biotech, Ltd
SVA
$55K ﹤0.01%
8,557
+2,000
+31% +$12.9K
AVDL
6300
DELISTED
Avadel Pharmaceuticals
AVDL
$54K ﹤0.01%
7,220
+2,770
+62% +$14.6K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.